^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    AR splice variant 7 expression

    i
    Entrez ID:
    367
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    Apply
    Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer (NCT03123978)
    Phase 1
    Mamta Parikh
    Completed
    Last update posted :
    04/26/2023
    Initiation :
    01/09/2017
    Primary completion :
    01/14/2022
    Completion :
    04/19/2022
    AR
    |
    AR expression • AR splice variant 7 • AR-V7 expression • AR splice variant 7 expression
    |
    Xtandi (enzalutamide) • niclosamide
    PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. (NCT02922218)
    Phase N/A
    Centro Nacional de Investigaciones Oncologicas ...
    Unknown status
    Last update posted :
    01/27/2020
    Initiation :
    06/01/2016
    Primary completion :
    01/01/2020
    Completion :
    12/01/2020
    PTEN • AR • ERG
    |
    AR amplification • AR splice variant 7 • AR-V7 expression • AR splice variant 7 expression
    |
    Xtandi (enzalutamide)